Allianz Asset Management Gmb H Bio Xcel Therapeutics, Inc. Transaction History

Allianz Asset Management Gmb H

  • $69.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$29.06 - $38.83 $517,180 - $691,057
-17,797 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$39.04 - $64.6 $360,378 - $596,322
9,231 Added 107.76%
17,797 $768,000
Q4 2020

Feb 16, 2021
BUY
$42.46 - $56.58 $363,712 - $484,664
8,566 New
8,566 $396,000

Others Institutions Holding BTAI

# of Institutions
55
Shares Held
3.14M
Call Options Held
22.2K
Put Options Held
40.2K
View Full List

About BioXcel Therapeutics, Inc.

BTAI Quotes by TradingView
  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $14.3M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email